Stock listing

IGC Stock Price, News, Filings & Events — Igc Pharma, Inc.

Selected listing: IGC · BOATS · USD · US

This page tracks Igc Pharma, Inc.'s IGC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IGC:BOATS. IGC:BOATS is the stock-level entry point for investors researching Igc Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Igc Pharma, Inc. is a public company traded on the American stock market under the ticker IGC. With a market capitalization of approximately $26.4 million, the company is focused on developing innovative therapies. Its operations are centered on advancing its pharmaceutical products and research initiatives.

IGC:BOATSUSDUSUpdated August 15, 2026
Igc Pharma, Inc. logo
Ticker
IGC:BOATS
Asset type
Stock
Market cap
$29.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Igc Pharma, Inc. IGC:BOATS stock context

This page tracks Igc Pharma, Inc.'s IGC:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IGC:BOATS. IGC:BOATS is the stock-level entry point for investors researching Igc Pharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Igc Pharma, Inc. is a public company traded on the American stock market under the ticker IGC. With a market capitalization of approximately $26.4 million, the company is focused on developing innovative therapies. Its operations are centered on advancing its pharmaceutical products and research initiatives.

Research Igc Pharma, Inc.

Alternate listings